Optimal management of bone metastases in breast cancer patients
Authors:
Open Access
- 1 May 2011
- journal article
- review article
- Published by Taylor & Francis in Breast Cancer: Targets and Therapy
- Vol. 3, 35-60
Abstract
Peer reviewed article authored by (Wong MH, Pavlakis N). Read article or submit your manuscript for publishing.Keywords
This publication has 98 references indexed in Scilit:
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- Role of chemokines in tumor growthCancer Letters, 2007
- Meta-analysis of clodronate and breast cancer survivalBritish Journal of Cancer, 2007
- Dickkopf Homolog 1 Mediates Endothelin-1-Stimulated New Bone FormationMolecular Endocrinology, 2007
- Zoledronic Acid Inhibits Visceral Metastases in the 4T1/luc Mouse Breast Cancer ModelClinical Cancer Research, 2004
- Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancerEuropean Journal of Cancer, 2004
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- An open randomised trial of second-line endocrine therapy in advanced breast cancerEuropean Journal of Cancer, 2003
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Risk of complications from bone metastases in breast cancerEuropean Journal of Cancer, 2000